Drug
Muraglitazar
Muraglitazar: highest development phase Phase 3, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| muraglitazar NCT00095030 | Phase 3 | Diabetes Mellitus, Type 2 |
Latest
No recent events.
Follow Muraglitazar on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.